To investigate the role of GSDMD in a distinct AKI model, we subjected wild-type mice to intraperitoneal injection of 20 mg/kg body weight cisplatin (cisplatin-induced AKI) and separated the mice into eight distinct groups. The gene discussed is GSDMD; the disease is acute kidney injury.